Viewing Study NCT02739633


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-02-20 @ 6:05 PM
Study NCT ID: NCT02739633
Status: UNKNOWN
Last Update Posted: 2018-04-18
First Post: 2016-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas
Sponsor: Samyang Biopharmaceuticals Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module